News

Bar-Ilan University scientist part of €8 million consortium to ensure accuracy in CAR-T cell therapy, an immunotherapy using CRISPR-Cas9, in European hospitals ...
NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...
CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...
This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...
Argentina, widely regarded as the global capital of polo, has welcomed cloning and other breeding innovations. But CRISPR is different – for now.
Scientists have achieved the first DNA-free CRISPR gene editing in raspberries, reaching 19% efficiency and opening the door to faster breeding of firmer, more resilient berries — though regenerating ...
The surgeons at Guangzhou Medical University performed this ground-breaking procedure, transplanting the left lung of a specially modified pig into a 39-year-old man who had been declared brain dead a ...
In a medical first, a pig lung was transplanted into a brain-dead human, where it functioned for nine days. Surgeons at ...
This highlights an important preclinical model that could be successful in humans. The notoriously persistent, ...
Discover why ASML's EUV lithography dominance, long-term AI & 5G trends, and recurring revenues make it a key player in ...
Single-celled species that often stick together in colonies have researchers rethinking the origin of animals.
Popular gene editing tools, such as CRISPR-Cas9, which are often used for creating a new host cell line for producing commercial biotherapeutics, require a specific license, and the intellectual ...